General Electric’s (GE - Free Report) Healthcare unit is making an $80 million investment at its Active Pharmaceutical Ingredients (API) site in Lindesnes, Norway to increase manufacturing capacity by 30%.
The investment, which is expected to create around 100 new jobs, is aimed at meeting future demand for iodinated contrast media across the globe. Iodinated contrast media is used in Xray and Computed Tomography (CT) procedures to enhance visualization of organs, blood vessels and tissues across disease pathways. GE Healthcare has a goal to produce 30 million more doses of contrast media per year by 2025.
General Electric expects global demand for iodinated contrast media to double in the next 10 years, owing to prevalence of chronic disorders and growth in CT procedures. Through the $80 million investment, the company aims to address “this growing demand to meet the needs of our customers and their patients across the globe".
The API site in Lindesnes, Norway is 100 acres and employs 450 people. The site has been operational since 1974. Recently, GE Healthcare has entered into a multi-year agreement with Sociedad Quimica y Minera de Chile for iodine supply, which is essential for iodinated contrast media.
Zacks Rank & Key Picks
General Electric currently carries a Zacks Rank #3 (Hold).
Some better-ranked companies are as follows:
Enerpac Tool Group Corp. (EPAC - Free Report) delivered an average four-quarter earnings surprise of 3.4%. EPAC presently sports a Zacks Rank #1 (Strong Buy). You can see the complete list of today’s Zacks #1 Rank stocks.
Enerpac Tool’s estimated earnings growth rate for the current fiscal year is 44.6%. Shares of the company have jumped 21% in the past six months.
Applied Industrial Technologies, Inc. (AIT - Free Report) presently carries a Zacks Rank #2 (Buy). The company delivered a trailing four-quarter earnings surprise of 24.8%, on average.
Applied Industrial has an estimated earnings growth rate of 14.3% for the current fiscal year. Shares of the company have gained 22.7% in the past six months.
IDEX Corporation (IEX - Free Report) presently has a Zacks Rank of 2. IDEX pulled off a trailing four-quarter earnings surprise of 5.7% on average.
IDEX has an estimated earnings growth rate of 28.3% for the current year. Shares of the company have rallied 27.5% in the past six months.
Zacks Names "Single Best Pick to Double"
From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all.
It’s an American AI company that’s riding low right now, but it has rounded up clients like BMW, GE, Dell Computer, and Bosch. It has prospects for not just doubling but quadrupling in the year to come. Of course, all our picks aren’t winners but this one could far surpass earlier Zacks’ Stocks Set to Double like Boston Beer Company which shot up +143.0% in little more than 9 months and NVIDIA which boomed +175.9% in one year.
Free: See Our Top Stock And 4 Runners Up
General Electric’s (GE - Free Report) Healthcare unit is making an $80 million investment at its Active Pharmaceutical Ingredients (API) site in Lindesnes, Norway to increase manufacturing capacity by 30%.
The investment, which is expected to create around 100 new jobs, is aimed at meeting future demand for iodinated contrast media across the globe. Iodinated contrast media is used in Xray and Computed Tomography (CT) procedures to enhance visualization of organs, blood vessels and tissues across disease pathways. GE Healthcare has a goal to produce 30 million more doses of contrast media per year by 2025.
General Electric expects global demand for iodinated contrast media to double in the next 10 years, owing to prevalence of chronic disorders and growth in CT procedures. Through the $80 million investment, the company aims to address “this growing demand to meet the needs of our customers and their patients across the globe".
The API site in Lindesnes, Norway is 100 acres and employs 450 people. The site has been operational since 1974. Recently, GE Healthcare has entered into a multi-year agreement with Sociedad Quimica y Minera de Chile for iodine supply, which is essential for iodinated contrast media.
Zacks Rank & Key Picks
General Electric currently carries a Zacks Rank #3 (Hold).
Some better-ranked companies are as follows:
Enerpac Tool Group Corp. (EPAC - Free Report) delivered an average four-quarter earnings surprise of 3.4%. EPAC presently sports a Zacks Rank #1 (Strong Buy). You can see the complete list of today’s Zacks #1 Rank stocks.
Enerpac Tool’s estimated earnings growth rate for the current fiscal year is 44.6%. Shares of the company have jumped 21% in the past six months.
Applied Industrial Technologies, Inc. (AIT - Free Report) presently carries a Zacks Rank #2 (Buy). The company delivered a trailing four-quarter earnings surprise of 24.8%, on average.
Applied Industrial has an estimated earnings growth rate of 14.3% for the current fiscal year. Shares of the company have gained 22.7% in the past six months.
IDEX Corporation (IEX - Free Report) presently has a Zacks Rank of 2. IDEX pulled off a trailing four-quarter earnings surprise of 5.7% on average.
IDEX has an estimated earnings growth rate of 28.3% for the current year. Shares of the company have rallied 27.5% in the past six months.
Zacks Names "Single Best Pick to Double"
From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all.
It’s an American AI company that’s riding low right now, but it has rounded up clients like BMW, GE, Dell Computer, and Bosch. It has prospects for not just doubling but quadrupling in the year to come. Of course, all our picks aren’t winners but this one could far surpass earlier Zacks’ Stocks Set to Double like Boston Beer Company which shot up +143.0% in little more than 9 months and NVIDIA which boomed +175.9% in one year.
Free: See Our Top Stock And 4 Runners Up
Get the latest research report on GE - FREE
Get the latest research report on AIT - FREE
Get the latest research report on IEX - FREE
Get the latest research report on EPAC - FREE